| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |